FN London

Financial News

News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

Banks are among the biggest risers on UK’s green light for Oxford-AstraZeneca vaccine

Lenders bounce back after post-Christmas fall as new inoculation is approved

By

Penny Sukhraj

The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December
The lift in banking stocks comes a day after bank stocks fell in the first post-Christmas trading, which analysts attributed to a lack of clarity of how markets would operate come 1 January, as the transition period for Brexit ends on 31 December Photo: Barry Lewis/Getty Images

Banking stocks were among the top climbers on the FTSE 100, which rose on 30 December on the back of the UK government’s approval of the Oxford-AstraZeneca coronavirus vaccine.

Pricing in the news of the vaccine saw an uptick across the banks including NatWest (+2.75%), Lloyds Banking Group (+2.24%), Standard Chartered (+2.03%), HSBC (+1.64%) and Barclays (+1.47%), along with financial services firms like Legal & General (1.81%).

WSJ Logo
Bank of England Keeps Rates Steady After Fed Move

Bank of England Keeps Rates Steady After Fed Move

Activist Investor Widens Call for Review of Rio Tinto’s Dual-Listing

Musk Draws First Blood With Spending Bill Bombshell

How the White House Functioned With a Diminished Biden in Charge

European Indexes Fall on Slower U.S. Rate Cut Projections